[Dermatomyositis and polymyositis: clinical aspects and treatment]
- PMID: 11965087
[Dermatomyositis and polymyositis: clinical aspects and treatment]
Abstract
Dermatomyositis and polymyositis are the two major idiopathic inflammatory myopathies. The Bohan and Peter's criteria are still useful despite the probably different pathogenesis of the two myopathies. Cutaneous manifestations of dermatomyositis include heliotrope rash and Gottron's papules. The heliotrope rash, with or without edema, in a distribution involving periorbital skin is very suggestive of the diagnosis. Papules may be found overlying the "kneedle" of the hand or the elbows, knees, feet. Periungueal erythema with telangiectasis were characteristic but not pathognomonic. Scalp involvement is common. Skin lesions of dermatomyositis may precede the development of the myopathy and may persist after the control of the myositis. Some patients have an amyopathic dermatomyositis with normal muscle-enzyme, magnetic resonance scan and muscle biopsy. Muscle disease affects the proximal muscles, is generally symmetrical and symptoms are fatigue, weakness and sometimes myalgia. Proximal dysphagia reflects an involvement of striated muscle of the pharynx or proximal esophagus. Camptocormia reflects a severe involvement of paravertebral muscle. Other systemic features may be seen: pulmonary involvement (mostly interstitial pneumonitis and hypoventilation), arthralgias or arthritis, cardiac involvement, vasculatis and calcinosis particularly in children or adolescents with dermatomyositis. Malignant disease is associated with idiopathic inflammatory myopathies with a frequency of approximatively 10 to 15% in dermatomyositis and 5 to 10% in polymyositis and is strongly correlated with age, more than 50% of the patient over 65 years old were found to have a cancer. In the absence of malignant disease, the mainstay therapy for dermatomyositis and polymyositis is systemic corticosteroids (mostly 1mg/kg). In the lake of response or high dose dependance, intravenous immunoglobulins or immunosuppressive drugs like methotrexate or azathioprine may be discuss. Cyclophosphamide show some effectiveness in interstitial pneumonitis. Cyclosporin might be effective in children, less in adults. The efficacy of tacrolimus, mycophenolate mofetil, leflunomide and anti-TNF therapy need some prospective studies to determine if there are of value in idiopathic inflammatory myositis.
Similar articles
-
[Polymyositis/dermatomyositis--clinical picture and treatment].Reumatizam. 2012;59(2):44-50. Reumatizam. 2012. PMID: 23745455 Croatian.
-
[Therapeutic strategies in idiopatic inflammatory myopathies].Rev Med Suisse. 2009 Apr 15;5(199):812-8. Rev Med Suisse. 2009. PMID: 19441746 French.
-
Inflammatory myopathies: evaluation and management.Semin Neurol. 2008 Apr;28(2):241-9. doi: 10.1055/s-2008-1062267. Semin Neurol. 2008. PMID: 18351525 Review.
-
[Three patients with divergent presentations of idiopathic inflammatory myopathy].Ned Tijdschr Geneeskd. 2002 May 4;146(18):833-8. Ned Tijdschr Geneeskd. 2002. PMID: 12038218 Dutch.
-
Dermatomyositis.Lancet. 2000 Jan 1;355(9197):53-7. doi: 10.1016/S0140-6736(99)05157-0. Lancet. 2000. PMID: 10615903 Review.
Cited by
-
Parkinson's disease with camptocormia.J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1223-8. doi: 10.1136/jnnp.2006.087908. Epub 2006 Jun 5. J Neurol Neurosurg Psychiatry. 2006. PMID: 16754693 Free PMC article.
-
[Dermatomyositis and rectal cancer: case study and literature review].Pan Afr Med J. 2019 Jun 18;33:122. doi: 10.11604/pamj.2019.33.122.14509. eCollection 2019. Pan Afr Med J. 2019. PMID: 31558922 Free PMC article. Review. French.